Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrés Redondo
Hospital Universitario La Paz
Principal Investigator - Anna Estival
Germans Trias i Pujol Hospital
Principal Investigator - Antonio Casado
Hospital San Carlos, Madrid
Principal Investigator - Antonio López-Pousa, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Claudia Valverde
Hospital Universitari Vall d'Hebrón
Principal Investigator - Diego Jara, MD
Hospital Universitario 12 de Octubre
Principal Investigator - Irene Carrasco García, MD
Hospitales Universitarios Virgen del Rocío
Study Director - Isabel Sevilla, MD
Hospital Universitario Virgen de la Victoria
Principal Investigator - Javier Lavernia
Instituto Valenciano de Oncología
Principal Investigator - Javier Martín Broto
Hospital Universitario Fundación Jiménez Díaz
Principal Investigator - Javier Martínez Trufero, MD
Hospital Miguel Servet
Principal Investigator - Jerónimo Martínez
Hospital Universitario Virgen de la Arrixaca
Principal Investigator - Josefina Cruz
Hospital Universitario de Canarias
Principal Investigator - Juan Luís García Llano, MD
Hospital Universitario Central de Asturias
Principal Investigator - Luís Miguel de Sande
Complejo Asistencial Universitario de León
Principal Investigator - Pablo Luna
Hospital Son Espases
Principal Investigator - Roberto Díaz, MD
Hospital Universitario La Fe
Study Director - Rosa Álvarez
Hospital General Universitario Gregorio Marañón
Principal Investigator - Xavier García del Muro
Institut Català d'Oncología l'Hospitalet
Principal Investigator - Yolanda Vidal, MD
Complejo Hospitalario Universitario de Santiago
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitari Germans Trias I Pujol
Barcelona, Spain
Recruiting - Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
Recruiting - Institut Català D'Oncología L'Hospitalet
Barcelona, Spain
Recruiting - Complejo Asistencial Universitario de León
León, Spain
Recruiting - Hospital Clínico San Carlos
Madrid, Spain
Recruiting - Hospital General Universitario Gregorio Marañon
Madrid, Spain
Recruiting - Hospital Universitario 12 de Octubre
Madrid, Spain
Recruiting - Hospital Universitario Fundación Jimenez Diaz
Madrid, Spain
Recruiting - Hospital Universitario la Paz
Madrid, Spain
Recruiting - Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Spain
Recruiting - Hospital Universitario Virgen de la Victoria
Málaga, Spain
Recruiting - Hospital Universitario Central de Asturias
Oviedo, Spain
Recruiting - Hospital Universitari Son Espases
Palma de Mallorca, Spain
Recruiting - Hospital Universitario de Canarias
Santa Cruz de Tenerife, Spain
Recruiting - Complejo Hospitalario Universitario de Santiago
Santiago de Compostela, Spain
Recruiting - Hospital Universitario Virgen del Rocío
Seville, Spain
Recruiting - Hospital Universitari I Politècnic la Fe
Valencia, Spain
Recruiting - Instituto Valenciano de Oncología
Valencia, Spain
Recruiting - Hospital Universitario Miguel Servet
Zaragoza, Spain
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2017
- Primary completion
- 30 Sept 2024
- Completion
- 30 Sept 2024
- Last update posted
- 23 Jan 2024
- Registered enrollment
- 40
- Registry id
- NCT03242382
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.